TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions

Neuropathology and Applied Neurobiology

Volumn 33, Issue 1, 2007, Pages 99-107

  Satoh, J ^a,b   Tabunoki, H ^a   Yamamura, T ^b   Arima, K ^c   Konno, H ^d  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c National Center of Neurology and Psychiatry   (Japan)

^d National Hospital Organization Sendai Nishitaga Hospital   (Japan)

Author keywords

LINGO 1; Macrophages microglia; Multiple sclerosis; Reactive astrocytes; TROY

Indexed keywords

LINGO 1 PROTEIN; MEMBRANE PROTEIN; PROTEIN NOGO A; RECEPTOR PROTEIN; TROY PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN DAMAGE; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; ASTROCYTES; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DEMYELINATING DISEASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; NEURONS; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 33846148013     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00787.x     Document Type: Article

References (21)

1. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85
2. Lassmann H. Axonal injury in multiple sclerosis. J Neurol Neurosurg Psychiatry 2003; 74: 695-7
3. Domeniconi M, Filbin MT. Overcoming inhibitors in myelin to promote axonal regeneration. J Neurol Sci 2005; 233: 43-7
4. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000; 403: 434-9
5. Wang X, Chun S-J, Treloar H, Vartanian T, Greer CA, Strittmatter SM. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002; 22: 5505-15
6. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002; 420: 74-8
7. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003; 6: 461-7
8. Josephson A, Trifunovski A, Widmer HR, Widenfalk J, Olson L, Spenger C. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 2002; 453: 292-304
9. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He Z. A TNF receptor family member, TROY, is a coreceptor with nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005; 45: 345-51
10. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, Thill G, Levesque M, Sah D, McCoy JM, Murray B, Jung V, Pepinsky RB, Mi S. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005; 45: 353-9
11. Kojima T, Morikawa Y, Copeland NG, Gilbert DJ, Jenkins NA, Senba E, Kitamura T. TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles. J Biol Chem 2000; 275: 20742-7
12. Hisaoka T, Morikawa Y, Kitamura T, Senba E. Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain. Dev Brain Res 2003; 143: 105-9
13. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004; 7: 221-8
14. Chen Y, Aulia S, Li L, Tang BL. AMIGO and friends: an emerging family of brain-derived, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs. Brain Res Rev 2006; 51: 265-74
15. Carim-Todd L, Escarceller M, Estivill X, Sumoy L. LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur J Neurosci 2003; 18: 3167-82
16. Satoh J, Onoue H, Arima K, Yamamura T. Nogo-A and Nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 129-38
17. Satoh J, Kuroda Y. Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: implications for inflammation-related axonal regeneration in the central nervous system. Neuropathol Appl Neurobiol 2002; 28: 95-106
18. Nagai A, Nakagawa E, Hatori K, Choi HB, McLarnon JG, Lee MA, Kim SU. Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines. Neurobiol Dis 2001; 8: 1057-68
19. Trifunovski A, Josephson A, Ringman A, Brené S, Spenger C, Olson L. Neuronal activity-induced regulation of Lingo-1. Neuroreport 2004; 15: 2397-400
20. Kurnellas MP, Nicot A, Shull GE, Elkabes S. Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury. FASEB J 2005; 19: 298-300
21. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005; 8: 745-51